Medicine News and Research

RSS

Endothelial cells can produce copious amounts of adult stem cells: Study

In a leap toward making stem cell therapy widely available, researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College have discovered that endothelial cells, the most basic building blocks of the vascular system, produce growth factors that can grow copious amounts of adult stem cells and their progeny over the course of weeks.

5 Mar 2010

ADA President outlines ways to improve oral health care access for underserved populations

American Dental Association President Dr. Ronald Tankersley testified today before an Institute of Medicine Committee on Oral Health Access to Services, outlining the ADA's efforts to address ways to improve access for underserved populations.

5 Mar 2010

Recipients for 2010 Scholar Awards announced

The American Society of Hematology announces the 2010 recipients of its Scholar Awards. The program is designed to support hematologists who have chosen a career in research by providing partial salary or other support during that critical period required for completion of training and achievement of status as an independent investigator.

5 Mar 2010

Vioxx: Australian Court dismisses all claims against Merck

Today, the Federal Court in Australia published its judgment in the Peterson case. The Court found against MSD Australia on two claims under Australian statutory provisions. The Court dismissed all claims against Merck & Co., Inc. specifically finding that Merck was not negligent in its development, scientific study and sale of Vioxx. Merck and MSD Australia disagree with the limited portions of the Court’s findings that were against MSD Australia and intend to appeal them.

5 Mar 2010

Gene involved in susceptibility and resistance to TB identified

University of Washington researchers have identified a gene involved in susceptibility and resistance to tuberculosis. This same gene, they have found, has a role in the severity of leprosy, which is caused by a related pathogen. The researchers also have learned why this gene is important for susceptibility.

5 Mar 2010

National healthcare leaders to address critical national healthcare reform issues at Hyatt Regency, San Francisco

National healthcare leaders will address critical national healthcare reform issues at the Hyatt Regency, San Francisco, March 8 -10, during the Fifth National Pay for Performance Summit.

5 Mar 2010

Latest diagnostic tools play crucial role in aiding dermatologists to spot melanomas at earlier

According to estimates from the American Cancer Society, melanoma, the most serious form of skin cancer, was responsible for an estimated 8,650 deaths in the United States in 2009. Of growing concern among dermatologists is the fact that melanoma is now the most common form of cancer for young adults 25-29 years old and the second most common cancer in adolescents and young adults 15-29 years old.

5 Mar 2010

South West Liver Unit researchers receive grants for developing Hepatitis C vaccine

Researchers at the South West Liver Unit, based at Plymouth Hospitals NHS Trust and supported by the Peninsula Medical School, are working to save more lives and improve the health of Hepatitis C sufferers around the world by developing a vaccine for the disease.

5 Mar 2010

RMEI, PIM jointly sponsor virtual lecture to address the need for education on ALL in AYAs

Currently, no definitive standard of care exists for adolescent and young adults (AYA) with acute lymphoblastic leukemia (ALL). Recent research suggests that AYAs treated with pediatric treatment protocols have better outcomes than those treated with adult treatment protocols.

5 Mar 2010

Chikungunya: Experimental vaccine successfully tested in monkeys

Imagine a mosquito-borne virus that has already infected millions of people in recent outbreaks in South and Southeast Asia, the islands of the Indian Ocean, Africa and northern Italy. Although seldom fatal, it causes highly painful arthritis-like symptoms that can linger for months or even years. It's capable of adapting to spread through a mosquito species common in much of North America. And no vaccine or treatment exists to protect humans from its effects.

5 Mar 2010

Study finds Pfizer's pneumonia, meningitis vaccine protects against recurrent pneumonia in HIV patients

Pfizer's Prevnar 7 vaccine, which protects against pneumonia and meningitis, has been shown to reduce the risk of recurrent pneumococcal infection in patients living with HIV in Malawi, according to a study published Thursday in the New England Journal of Medicine, Reuters reports.

5 Mar 2010

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

The second American Association for Cancer Research Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic provides attendees with an overview of the most advanced cancer research in a variety of fields, including the tumor microenvironment, microRNAs, signal transduction and novel therapeutic development.

5 Mar 2010

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

Data evaluating the efficacy and safety of STELARA™ (ustekinumab) and REMICADE® (infliximab) in patients with plaque psoriasis who had an inadequate response to Enbrel® (etanercept) will be presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) in Miami, Fla., from March 5-9, 2010.

5 Mar 2010

BioClinica announces partnerships with Health Sciences International and PRL Central Laboratory Services

BioClinica™, Inc.,, a global provider of clinical trial management services, today announced it has created strategic partnerships with two clinical research organizations (CROs), Health Sciences International, Inc., and PRL Central Laboratory Services. Both alliances strengthen the BioClinica Certified Partner Program, a group of VIP CRO partners chosen based on therapeutic expertise and customer satisfaction.

From Clario 5 Mar 2010

Risk of MS increases by many folds following infection with EBV: Study

Researchers from the Harvard School of Public Health, Walter Reed Army Institute of Research, and a team of collaborators have observed for the first time that the risk of multiple sclerosis (MS) increases by many folds following infection with the Epstein-Barr virus (EBV).

5 Mar 2010

Sebelius meets with insurance execs, challenges them to be transparent

Reuters: During a meeting today, Health and Human Services Secretary Kathleen Sebelius pressed the CEOs of some of the nation's largest health insurers about increases in insurance premiums. "The meeting added more uncertainty for an industry that has already become Democrats' top target in their bid to overhaul the nation's healthcare system, and shares of health insurers continued to fall in late-morning trading."

5 Mar 2010

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte’s lead regenerative medicine product using Xcellerex’s XDR single use bioreactor system in its FlexFactory®. Humacyte’s product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.

5 Mar 2010

MedCAREERS GROUP to acquire StaffMD

MedCAREERS GROUP, Inc. today announced that it has signed a letter of intent to acquire StaffMD a leading online job posting website in the physician staffing industry. StaffMD operates primarily under the name www.physicianwork.com, but it has other operating assets as well. StaffMD was founded ten years ago by Jeffrey Sisk and he will remain with the Company after the closing of the pending acquisition.

5 Mar 2010

Proper diagnosis, treatment and good skin care help control acne and rosacea

Acne and rosacea are two seemingly different skin conditions that have one important thing in common: both are chronic and extremely common skin conditions. However, dermatologists recommend that with proper diagnosis, treatment and a healthy dose of good, old-fashioned skin care, acne and rosacea can be less of a nuisance for patients.

5 Mar 2010

FDA approves CSL Behring's Hizentra for PI

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for HizentraTM, Immune Globulin Subcutaneous (Human), 20% Liquid, for treating patients diagnosed with primary immunodeficiency (PI). A once weekly immunoglobulin (Ig) replacement therapy, Hizentra provides effective protection against infection by maintaining a steady and normal level of immunoglobulin in the body.

4 Mar 2010

Medicine News and Research

Endothelial cells can produce copious amounts of adult stem cells: Study

ADA President outlines ways to improve oral health care access for underserved populations

Recipients for 2010 Scholar Awards announced

Vioxx: Australian Court dismisses all claims against Merck

Gene involved in susceptibility and resistance to TB identified

National healthcare leaders to address critical national healthcare reform issues at Hyatt Regency, San Francisco

Latest diagnostic tools play crucial role in aiding dermatologists to spot melanomas at earlier

South West Liver Unit researchers receive grants for developing Hepatitis C vaccine

RMEI, PIM jointly sponsor virtual lecture to address the need for education on ALL in AYAs

Chikungunya: Experimental vaccine successfully tested in monkeys

Study finds Pfizer's pneumonia, meningitis vaccine protects against recurrent pneumonia in HIV patients

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

BioClinica announces partnerships with Health Sciences International and PRL Central Laboratory Services

Risk of MS increases by many folds following infection with EBV: Study

Sebelius meets with insurance execs, challenges them to be transparent

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

MedCAREERS GROUP to acquire StaffMD

Proper diagnosis, treatment and good skin care help control acne and rosacea

FDA approves CSL Behring's Hizentra for PI

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News